Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Personalised T Cell Activator Shows Promise
February 2026
A personalised multipeptide T cell activator induced durable immune responses and showed an acceptable safety profile in patients with chronic lymphocytic leukaemia in a phase one trial.
Read more
31 Jan 2026
Human Parvovirus B19 Drives Bone Marrow Failure
Parvovirus B19 was shown to infect haematopoietic stem cells, impairing self renewal and differentiation, with JAK2 STAT5 inhibition partially reversing virus induced bone marrow dysfunction.
29 Jan 2026
Dasatinib Enhances Immune Activation in Philadelphia Leukaemia
Dasatinib plus blinatumomab demonstrated greater and sustained immune activation than ponatinib combinations in Ph+ acute lymphoblastic leukaemia, with marked effects on lymphocytes and natural killer cells.
27 Jan 2026
Liver Transplant in Children with Anaemia
Early haematopoietic stem cell transplantation after liver transplantation resulted in 90% survival in children with hepatitis-associated aplastic anaemia, with normal blood counts and liver function at follow up.
25 Jan 2026
Hetrombopag Effective in Paediatric Immune Thrombocytopenia
Hetrombopag achieved an overall response in over three quarters of paediatric patients with immune thrombocytopenia, with durable responses and no serious adverse events reported.
24 Jan 2026
Red Blood Cell Immunisation Linked to Reduced Survival in MDS
RBC immunization affects over 14% of transfused patients with myelodysplastic syndromes and is independently associated with markedly reduced survival, highlighting its emerging prognostic relevance.
22 Jan 2026
Hydroxyurea Pregnancy Outcomes Reassure Sickle Cell Clinicians
The ESCORT-HU and ESCORT-HU Extension studies followed 3,145 patients, with 1412 (45%) men and 1733 (55%) women….
20 Jan 2026
Marked Haematologic Cancer Risk in Enlarged Spleens
Individuals with large spleens face increased risk of hematologic cancer and liver disease, supporting the use of spleen size thresholds in clinical assessment.
17 Jan 2026
HARMONY Model Enhances Risk Assessment in AML
A new genetic classification integrating co-mutations significantly refines risk stratification in NPM1-mutated AML and may guide allogeneic transplant decisions in first complete remission.
Loading posts...
« Previous
1
2
3
4
…
45
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View